TrialCancer2021

Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.

Filipa Lynce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.